Early real-world outcomes in patients with neovascular Age-related Macular Degeneration (nAMD) treated with Faricimab

被引：0
|
作者：
Raslan, Walid [1 ]
Younis, Saad [1 ]
Fabozzi, Lorenzo [2 ]
Hassan, Islam [1 ]
Palmieri, Filomena [1 ]
机构：
[1] Western Eye Hosp London, London, England
[2] Moorfields Eye Hosp NHS Fdn Trust London, London, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Real-World Outcomes of Faricimab Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    Quah, Nicole Q. X.
    Javed, Khawaja Muhammad Ammar Ali
    Arbi, Lamees
    Hanumunthadu, Daren
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 1479 - 1490
  • [2] 1-Year real-world outcomes of faricimab in previously treated neovascular age-related macular degeneration
    Janmohamed, Imran Karim
    Mushtaq, Adeel
    Kabbani, Jamil
    Harrow, Simeon
    Nadarajasundaram, Aaruran
    Ata, Anibe
    Monye, Henrietta
    Jarrar, Zakariya
    Hannan, Shabeeba
    Membrey, Luke
    EYE, 2025,
  • [3] One-Year Real-World Outcomes of Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
    Cancian, Giuseppe
    Paris, Arianna
    Agliati, Lia
    Rizzato, Angelica
    Clerici, Michele
    Volpe, Giulio
    Menghini, Moreno
    Grimaldi, Gabriela
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (11) : 2985 - 2997
  • [4] BUDGET IMPACT OF FARICIMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) IN IRELAND
    de Greeff, J.
    Goodwin, M.
    VALUE IN HEALTH, 2024, 27 (12)
  • [5] Real -world clinical and anatomical outcomes in patients with neovascular age -related macular degeneration (nAMD) treated with faricimab: The FARETINA-AMD study
    Tabano, David
    Ko, Stella
    Borkar, Durga
    Leng, Theodore
    Ali, Ferhina
    Shaia, Jacqueline K.
    Myers, Rachel
    LaPrise, Andrew
    Singh, Rishi P.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [6] Clinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration
    Pandit, Saagar A.
    Momenaei, Bita
    Wakabayashi, Taku
    Mansour, Hana A.
    Vemula, Sudheshna
    Durrani, Asad F.
    Pashaee, Bahram
    Kazan, Adina S.
    Ho, Allen C.
    Klufas, Michael
    Regillo, Carl
    Yonekawa, Yoshihiro
    Hsu, Jason
    Kuriyan, Ajay
    Chiang, Allen
    OPHTHALMOLOGY RETINA, 2024, 8 (04): : 360 - 366
  • [7] REAL-WORLD LONG-TERM OUTCOMES OF INTRAVITREAL FARICIMAB IN PREVIOUSLY TREATED CHRONIC NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Ambati, Naveen R.
    Leone, Adam
    Brill, Daniel
    Sisk, Robert A.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2025, 45 (03): : 446 - 453
  • [8] The Real-World Efficacy and Safety of Faricimab in Neovascular Age-Related Macular Degeneration: The TRUCKEE Study
    Aziz, Aamir Abdul
    Khan, Hannah
    Abbey, Ashkan Michael
    Almeida, David R. P.
    Avery, Robert L.
    Banda, Himanshu K.
    Barakat, Mark
    Bhandari, Ramanath
    Chang, Emmanuel Y.
    Haug, Sara
    London, Nikolas J. S.
    Sheth, Veeral
    Wolfe, Jeremy
    Singer, Michael Andrew
    Danzig, Carl J.
    Khanani, Arshad M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [9] Real-world efficacy of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review
    Nasimi, Nasratullah
    Nasimi, Safiullah
    Grauslund, Jakob
    Vergmann, Anna Stage
    Subhi, Yousif
    INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, 2024, 10 (01)
  • [10] Real -world outcomes of faricimab injections in treatment -na ve neovascular age -related macular degeneration (nAMD) patients: The Moorfields Experience
    Sim, Sing Yue
    Nicholson, Luke
    Patel, Praveen J.
    Bhatia, Bhairavi
    Chalkiadaki, Evangelia
    Koutsocheras, Georgios
    Selvam, Senthil
    Sivaprasad, Sobha
    Pal, Bishwanath
    Keane, Pearse Andrew
    Hamilton, Robin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
12345